Equipment and Services Health Care Equipment and Supplies

  • But, instead of reporting the events to the U.S. Food and Drug Administration, within 30 days of discovering them, as required by law, Medtronic hid them, the Star Tribune said. Medtronic officials told the Star Tribune that the database of adverse events was misfiled internally and was reported to the FDA after it was rediscovered more than five years later.

  • A doctor uses a robotic surgery device to operate on a patient.

    With a grant from the Defense Department, a Florida medical center is creating a video game to train doctors for robotic surgery.

  • April 6- Medtronic Plc's wireless pacemaker was approved by the U.S. Food and Drug Administration on Wednesday, making it the first pacemaker in the United States that does not need wired leads to correct slow heart rates. The FDA evaluated data from a clinical trial involving 719 and found that 98 percent of patients had a stable heart pacing for at least six...

  • April 6- Medtronic Plc's wireless pacemaker was approved in the United states on Wednesday, making it the first pacemaker that does not need wired leads to correct slow heart rate. The device named Micra pacemaker is delivered to the heart chambers through a patient's arteries through a catheter, unlike traditional pacemakers that are implanted through an...

  • The Health Information Trust Alliance conducted a study of some 30 mid-sized U.S. hospitals late last year and found that 52 percent of them were infected with malicious software, HITRUST Chief Executive Daniel Nutkis told Reuters. Last month, Hollywood Presbyterian Hospital in Los Angeles paid a ransom of $17,000 to regain access to its systems.

  • A woman wears an early prototype of a bio-artificial pancreas (BAP) at the European Center for the Study of Diabetes on July 3, 2014, in Strasbourg, eastern France.

    It's hoped the FDA will approve an artificial pancreas in 2017. The device is expected to transform treatment of type 1 diabetes.

  • March 28- MedStar Health, one of the biggest medical providers in the Washington, D.C., area, said on Monday it shut down some computer systems after the discovery of a computer virus. "Networks temporarily shut down to prevent virus spread," MedStar, the operator of 10 hospitals in Washington and Maryland, said on Twitter. The Washington Post quoted MedStar...

  • March 23- Respironics Inc has agreed to pay $34.8 million to settle U.S. Department of Justice claims that it provided kickbacks in the form of free call center services to suppliers, to induce them to buy its masks for patients suffering from sleep apnea. Gibran Ameer, a South Carolina pharmacist who worked for medical equipment suppliers that bought the masks.

  • NEW YORK, March 17- Johnson& Johnson and its DePuy unit were ordered by a Texas federal jury on Thursday to pay about $500 million to five plaintiffs who said they were injured by Pinnacle metal-on-metal hip implants. Jurors awarded about $140 million in total compensatory damages and about $360 million in punitive damages, said Mark Lanier, lead trial counsel...

  • March 1- Medical device maker Medtronic Plc reported a nearly 61 percent rise in quarterly revenue, helped by higher sales across most of its units. The Dublin- based company's net income rose to $1.10 billion, or 77 cents per share, in the third quarter ended Jan. 29, from $977 million, or 98 cents per share, a year earlier. Revenue rose to $6.93 billion from $4.32 billion.

  • The U.S. Food and Drug Administration also asked the German drugmaker to conduct a post-market study of the device. Essure, acquired by Bayer in 2013, has been the target of complaints and calls for its withdrawal since it was approved for sale in the United States in 2002.. FDA said it intends to require the product to carry a "black box" label warning of serious...

  • Feb 29- The U.S. Food and Drug Administration has asked German drugmaker Bayer AG to conduct further studies on its controversial birth control device, Essure, and recommended that the product label contains the most restrictive type of warning. The FDA has instructed Bayer to conduct a clinical study to determine heightened risks for some women and has issued...

  • Feb 29- The U.S. Food and Drug Administration said on Monday it had asked German drugmaker Bayer AG to conduct further studies on its implantable sterilization device, Essure, following thousands of complaints and calls for its withdrawal. However, the FDA has received thousands of complaints over the years, including reports of the device breaking or moving...

  • Feb 29- The U.S. Food and Drug Administration said on Monday it had asked German drugmaker Bayer AG to conduct further studies on its implantable sterilization device, Essure, following thousands of complaints and calls for its withdrawal. However, the FDA has received thousands of complaints over the years, including reports of the device breaking or moving...

  • Feb 29- The U.S. Food and Drug Administration on Monday unveiled new measures to evaluate the risk of Bayer AG's implantable steralization device, Essure, following patient complaints and calls for its withdrawal from the market. The FDA has since received thousands of complaints, including reports of the device breaking or moving and causing injuries.

  • In an interview with CNBC, the NIH director said people may be "a little cynical" because of cancer's casualty rate, but researchers 'had its number.'

  • A man walks out of the Univista Insurance company office after shopping for a health plan under the Affordable Care Act, on December 15, 2015, in Miami.

    Mount Sinai Hospital's CEO told CNBC that while Obamacare survived a repeal attempt, it's locked in a tough game of numbers.

  • The future of fitness may be at home

    Peloton Cycle CEO John Foley explains how the company behind indoor cycling technology is experiencing massive growth.

  • Open Bionics teams up with Marvel and Disney to produce prosthetics for kids.

    New advances provide new hope for prosthetics, including an accurate sense of touch and robotic limbs developed at a fraction of the cost.

  • DNA human genome

    Before testing your own genome, it helps to realize it can raise more questions than it answers.